The Prevalence and Associated Factors of Sleep Disturbance in Menopause at Menopause Clinic, King Chulalongkorn Memorial Hospital

Main Article Content

Nichakorn Sirisivanart
Naphat Sirinimnualkul
Nalina Orprayoon

Abstract

Objective: This study aimed to evaluate the prevalence of insomnia at a Menopause clinic in a tertiary hospital and to identify the associated factors of insomnia.


Methods: A survey of 102 female patients aged 45 - 60 at a Menopause Clinic collected demographic data, Insomnia Severity Index (ISI) scores, and Thai Hospital Anxiety and Depression Scale scores. Descriptive statistics, univariate, and multivariate logistic regression analyses were used to identify associations.


Results: The prevalence of insomnia was 52% (ISI ≥ 8). Anxiety symptoms were significantly associated with insomnia (OR 12.57, 95% CI 1.56 - 101.50, p-value = 0.018). Multivariate logistic regression analyses revealed significant associations between insomnia and currently using hormone replacement therapy (aOR 0.36, 95% CI 0.13 - 0.97, p-value = 0.044).


Conclusion: Insomnia is highly prevalent among menopausal women, especially those with anxiety, while usage of hormone replacement therapy has been shown to alleviate symptoms. Clinicians should emphasize the assessment of anxiety and insomnia in menopausal women to provide appropriate care. A comprehensive evaluation of other mental health conditions, vasomotor symptoms, and history of hormonal therapy is crucial for determining the most effective treatment approach.

Article Details

How to Cite
Sirisivanart, N., Sirinimnualkul, N. ., & Orprayoon, N. (2025). The Prevalence and Associated Factors of Sleep Disturbance in Menopause at Menopause Clinic, King Chulalongkorn Memorial Hospital. Journal of the Psychiatric Association of Thailand, 70(2), 297–305. retrieved from https://he01.tci-thaijo.org/index.php/JPAT/article/view/276186
Section
Original Articles

References

Kessler RC, Berglund PA, Coulouvrat C, Hajak G, Roth T, Shahly V, et al. Insomnia and the performance of US workers: results from the America insomnia survey. Sleep 2011;34(9):1161-71.

Walsh JK, Coulouvrat C, Hajak G, Lakoma MD, Petukhova M, Roth T, et al. Nighttime insomnia symptoms and perceived health in the America Insomnia Survey (AIS). Sleep 2011;34(8):997-1011.

Roth T, Coulouvrat C, Hajak G, Lakoma MD, Sampson NA, Shahly V, et al. Prevalence and perceived health associated with insomnia based on DSM-IV-TR; International statistical classification of diseases and related health problems, tenth revision; and research diagnostic criteria/International classification of sleep disorders, second edition criteria: results from the America Insomnia Survey. Biol Psychiatry 2011;69(6):592-600.

Lu JL, Freire AX, Molnar MZ, Kalantar-Zadeh K, Kovesdy CP. Association of chronic insomnia with mortality and adverse renal outcomes. Mayo Clin Proc 2018;93(11):1563-70.

Wu MP, Lin HJ, Weng SF, Ho CH, Wang JJ, Hsu YW. Insomnia subtypes and the subsequent risks of stroke: report from a nationally representative cohort. Stroke 2014;45(5):1349-54.

de Almondes KM, Costa MV, Malloy-Diniz LF, Diniz BS. Insomnia and risk of dementia in older adults: systematic review and meta-analysis. J Psychiatr Res 2016;77:109-15.

LeBlanc ES, Smith NX, Nichols GA, Allison MJ, Clarke GN. Insomnia is associated with an increased risk of type 2 diabetes in the clinical setting. BMJ Open Diabetes Res Care 2018;6(1):e000604.

Department of Mental Health. World sleep day [Internet]. Nonthaburi (TH): Department of Mental Health; 2021 [cited 2024 Aug 29]. Available from: https://dmh.go.th/news-dmh/view.asp?id=30646.

World Health Organization. Menopause [Internet]. Geneva: World Health Organization; 2022 [cited 2024 Aug 29]. Available from: https://www.who.int/news-room/fact-sheets/detail/menopause.

Caruso D, Masci I, Cipollone G, Palagini L. Insomnia and depressive symptoms during the menopausal transition: theoretical and therapeutic implications of a self-reinforcing feedback loop. Maturitas 2019;123:78-81.

Ohayon MM. Severe hot flashes are associated with chronic insomnia. Arch Intern Med 2006;166(12):1262-8.

Zigmond AS, Snaith RP. The hospital anxiety and depression scale. Acta Psychiatr Scand 1983;67(6):361-70.

Morin CM, Belleville G, Bélanger L, Ivers H. The Insomnia Severity Index: psychometric indicators to detect insomnia cases and evaluate treatment response. Sleep 2011;34(5):601-8.

Keawphang P. Relationships between selected factors and insomnia in adult cancer patients. Chulalongkorn university: Chulalongkorn university; 2004.

Vittinghoff E, McCulloch CE. Relaxing the rule of ten events per variable in logistic and cox regression. Am J Epidemiol 2007;165(6):710-8.

Terauchi M, Obayashi S, Akiyoshi M, Kato K, Matsushima E, Kubota T. Insomnia in Japanese peri- and postmenopausal women. Climacteric 2010;13(5):479-86.

Sun D, Shao H, Li C, Tao M. Sleep disturbance and correlates in menopausal women in Shanghai. J Psychosom Res 2014;76(3):237-41.

Chung KF, Tang MK. Subjective sleep disturbance and its correlates in middle-aged Hong Kong Chinese women. Maturitas 2006;53(4):396-404.

NIH State-of-the-Science Conference Statement on management of menopause-related symptoms. NIH Consens State Sci Statements 2005;22(1):1-38.

Pengo MF, Won CH, Bourjeily G. Sleep in women across the life span. Chest 2018;154(1):196-206.

Hsu HC, Lin MH. Exploring quality of sleep and its related factors among menopausal women. J Nurs Res 2005;13(2):153-64.

Cheng M-H, Hsu C-Y, Wang S-J, Lee S-J, Wang P-H, Fuh J-L. The relationship of self-reported sleep disturbance, mood, and menopause in a community study. Menopause 2008;15(5):958-62.

Proserpio P, Marra S, Campana C, Agostoni EC, Palagini L, Nobili L, et al. Insomnia and menopause: a narrative review on mechanisms and treatments. Climacteric 2020;23(6):539-49.